Skip to main content
Watch Insiders
BBIOHealthcare

BridgeBio Pharma Inc (BBIO) Insider Trading

In the last 90 days, 1 BridgeBio Pharma Inc (BBIO) insider reported no open-market purchases and 2 sales totaling $4,418,097. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Sep 17, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Sep 17, 2026Neil KumarChief Executive OfficerSale10,000$69.08$690,847
Aug 19, 2026Neil KumarChief Executive OfficerSale44,980$82.86$3,727,250
Jul 30, 2026Maricel ApuliChief Accounting OfficerSale2,000$80.06$160,120
Jul 9, 2026Andrea EllisCorporate insiderSale17,167$84.00$1,442,028
Jul 9, 2026Jennifer E. CookCorporate insiderSale148,589$88.54$13,156,011
Jun 24, 2026Jennifer E. CookCorporate insiderSale39,363$69.92$2,752,269
Jun 23, 2026Hannah ValantineCorporate insiderSale5,004$68.25$341,524
Jun 15, 2026Jennifer E. CookCorporate insiderSale90,240$66.62$6,012,159
Jun 5, 2026Neil KumarChief Executive OfficerSale80,000$67.67$5,413,288
May 21, 2026Neil KumarChief Executive OfficerSale26,103$69.44$1,812,522
🔒 Create Free Insider Alerts — Join Watch Insiders

Common questions

BBIO insider trading FAQ

Are BBIO insiders buying or selling?
Over the last 90 days, BBIO insiders were net sellers, reporting $0.00 of open-market purchases and $4,418,097 of sales.
When was the last BBIO insider purchase?
No open-market insider purchase of BridgeBio Pharma Inc stock was reported in the last 90 days.
Where does BBIO insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that BridgeBio Pharma Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.